ProKidney Corp. Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
2020
2019
0M
-
3M
-3M
148M
45M
107M
-152M
0M
-129M
2M
-35M
-76.06%
152M
21M
-148M
3M
-152M
0M
-
3M
-3M
153M
71M
82M
-153M
0M
-147M
1M
-148M
168.62%
153M
6M
-144M
3M
-153M
0M
-
2M
-2M
55M
9M
46M
-55M
0M
-55M
0M
-55M
106.16%
55M
0M
-53M
2M
-55M
0M
-
0M
0M
27M
6M
21M
-27M
0M
-27M
0M
-27M
33,497.94%
27M
0M
-26M
1M
-27M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
33,497.94%
0M
0M
0M
0M
0M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
4Q2021
3Q2021
2Q2021
1Q2021
4Q2020
0M
-
1M
-1M
23M
2M
23M
-24M
0M
-19M
3M
-6M
-76.80%
24M
5M
-23M
1M
-24M
0M
-
1M
-1M
47M
14M
32M
-30M
0M
-41M
1M
-31M
-8.66%
47M
6M
-30M
1M
-31M
0M
-100.00%
1M
-1M
40M
13M
26M
-40M
0M
-34M
1M
-9M
-58.80%
40M
6M
-33M
1M
-34M
0M
-
1M
-1M
41M
15M
26M
-41M
0M
-36M
1M
-37M
-45.31%
41M
5M
-35M
1M
-41M
0M
-
1M
-1M
30M
9M
21M
-30M
0M
-26M
-1M
-25M
79.76%
30M
4M
-25M
1M
-30M
0M
-
1M
-1M
36M
14M
21M
-36M
0M
-34M
0M
-34M
98.02%
36M
2M
-33M
1M
-36M
0M
-
0M
0M
21M
9M
12M
-21M
0M
-21M
1M
-22M
73.92%
21M
0M
-21M
1M
-21M
0M
-
0M
0M
66M
38M
28M
-66M
0M
-66M
1M
-67M
481.32%
66M
0M
-66M
1M
-66M
0M
-
0M
0M
14M
3M
11M
-14M
0M
-14M
0M
-14M
481.32%
14M
0M
-13M
1M
-14M
0M
-
0M
0M
17M
2M
15M
-17M
0M
-17M
0M
-17M
481.32%
17M
0M
-17M
1M
-17M
0M
-
0M
0M
13M
2M
11M
-13M
0M
-13M
0M
-13M
481.32%
13M
0M
-12M
1M
-13M
0M
-
0M
0M
12M
2M
10M
-12M
0M
-12M
0M
-12M
481.32%
12M
0M
-11M
0M
-12M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
481.32%
0M
0M
0M
0M
-8M